Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.

Added 194 days ago (04.11.2021)
Authors: Chable-Bessia, C., Boulle, C., Neyret, A., Swain, J. M., Henaut, M., Merida, P., Gros, N., Makinson, A., Lyonnais, S., Chesnais, C. B., Muriaux, D.
Source: bioRxiv
Read article